Summary
8.59 0.05(0.59%)11/04/2024
Abacus Life, Inc. (ABL)
Abacus Life, Inc. (ABL)
Key Facts
| 1 Day | 1 Week | 1 Month | 3 Months | 6 Months | 1 Year | 5 Years | All Time |
| 0.59 | -0.66 | 0.76 | -3.15 | 78.27 | 0.00 | 0.00 | 63.66 |
Last 730 data points are shown. To view all data, Upgrade to PRO plan with only $1
| Trading Data | ||
| Close | 8.59 | |
| Open | 8.51 | |
| High | 8.65 | |
| Low | 8.42 | |
| Volume | 16,036 | |
| Change | 0.05 | |
| Change % | 0.59 | |
| Avg Volume (20 Days) | 17,328 | |
| Volume/Avg Volume (20 Days) Ratio | 0.93 | |
| 52 Week Range | 0.00 - 0.00 | |
| Price vs 52 Week High | inf% | |
| Price vs 52 Week Low | inf% | |
| Range | -0.42 | |
| Gap Up/Down | -0.07 | |
Fundamentals | ||
| Market Capitalization (Mln) | 773 | |
| EBIDTA | 0 | |
| PE Ratio | 0.0000 | |
| PEG Ratio | 0.0000 | |
| WallStreet Target Price | 0.00 | |
| Book Value | 0.0000 | |
| Earnings Per Share | 0.0000 | |
| EPS Estimate Current Quarter | 0.0000 | |
| EPS Estimate Next Quarter | 0.0000 | |
| EPS Estimate Current Year | 0.0000 | |
| EPS Estimate Next Year | 0.0000 | |
| Diluted EPS (TTM) | 0.0000 | |
| Revenues | ||
| Profit Marging | 0.0000 | |
| Operating Marging (TTM) | 0.0000 | |
| Return on asset (TTM) | 0.0000 | |
| Return on equity (TTM) | 0.0000 | |
| Revenue TTM | 0 | |
| Revenue per share TTM | 0.0000 | |
| Quarterly Revenue Growth (YOY) | 0.0000 | |
| Quarterly Earnings Growth (YOY) | 0.0000 | |
| Gross Profit (TTM) | 0 | |
| Dividends | ||
| Dividend Share | 0.0000 | |
| Dividend Yield | ||
| Valuations | ||
| Trailing PE | 0.0000 | |
| Forward PE | 0.0000 | |
| Price Sales (TTM) | 0.0000 | |
| Price Book (MRQ) | 0.0000 | |
| Revenue Enterprise Value | 0.0000 | |
| EBITDA Enterprise Value | 0.0000 | |
| Shares | ||
| Shares Outstanding | 0 | |
| Shares Float | 0 | |
| Shares Short | 0 | |
| Shares Short (Prior Month) | 0 | |
| Shares Ratio | 0.00 | |
| Short Outstanding (%) | 0.00 | |
| Short Float (%) | 0.00 | |
| Insider (%) | 0.00 | |
| Institutions (%) | 0.00 | |
10/31 11:07 EST - zacks.com
Abacus Life, Inc. (ABL) Earnings Expected to Grow: Should You Buy?
Abacus Life, Inc. (ABL) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Abacus Life, Inc. (ABL) Earnings Expected to Grow: Should You Buy?
Abacus Life, Inc. (ABL) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
10/17 10:08 EST - businesswire.com
Cambridge Savings Bank Extends New Credit Facility to Accelerate Growth for Fabrizia Spirits
CAMBRIDGE, Mass.--(BUSINESS WIRE)-- #SMBs--Cambridge Savings Bank has provided a new credit facility to Fabrizia Spirits, a leading citrus spirits manufacturer in the United States.
Cambridge Savings Bank Extends New Credit Facility to Accelerate Growth for Fabrizia Spirits
CAMBRIDGE, Mass.--(BUSINESS WIRE)-- #SMBs--Cambridge Savings Bank has provided a new credit facility to Fabrizia Spirits, a leading citrus spirits manufacturer in the United States.
10/11 09:00 EST - globenewswire.com
Abacus Life to Announce Third Quarter 2024 Financial Results on Thursday, November 7, 2024
ORLANDO, Fla., Oct. 11, 2024 (GLOBE NEWSWIRE) -- Abacus Life, Inc. (“Abacus” or the “Company”) (NASDAQ: ABL), a leading global alternative asset manager focused on lifespan-based financial products, today announced it will release its Third Quarter 2024 financial results after the market closes on Thursday, November 7, 2024.
Abacus Life to Announce Third Quarter 2024 Financial Results on Thursday, November 7, 2024
ORLANDO, Fla., Oct. 11, 2024 (GLOBE NEWSWIRE) -- Abacus Life, Inc. (“Abacus” or the “Company”) (NASDAQ: ABL), a leading global alternative asset manager focused on lifespan-based financial products, today announced it will release its Third Quarter 2024 financial results after the market closes on Thursday, November 7, 2024.
09/24 13:02 EST - zacks.com
What Makes Abacus Life, Inc. (ABL) a Strong Momentum Stock: Buy Now?
Does Abacus Life, Inc. (ABL) have what it takes to be a top stock pick for momentum investors? Let's find out.
What Makes Abacus Life, Inc. (ABL) a Strong Momentum Stock: Buy Now?
Does Abacus Life, Inc. (ABL) have what it takes to be a top stock pick for momentum investors? Let's find out.
09/19 15:46 EST - zacks.com
Buy 4 Low-Beta Stocks & Forget About Volatility: ERIE, SFM, AVO, ABL
It is imperative to build a portfolio of low-beta stocks to sail through a volatile market. ERIE, SFM, AVO & ABL are well-poised to gain.
Buy 4 Low-Beta Stocks & Forget About Volatility: ERIE, SFM, AVO, ABL
It is imperative to build a portfolio of low-beta stocks to sail through a volatile market. ERIE, SFM, AVO & ABL are well-poised to gain.
09/19 12:16 EST - zacks.com
Strength Seen in Abacus Life, Inc. (ABL): Can Its 5.4% Jump Turn into More Strength?
Abacus Life, Inc. (ABL) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock suggests that there could be more strength down the road.
Strength Seen in Abacus Life, Inc. (ABL): Can Its 5.4% Jump Turn into More Strength?
Abacus Life, Inc. (ABL) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock suggests that there could be more strength down the road.
09/19 10:55 EST - zacks.com
Does Abacus Life, Inc. (ABL) Have the Potential to Rally 34.62% as Wall Street Analysts Expect?
The mean of analysts' price targets for Abacus Life, Inc. (ABL) points to a 34.6% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
Does Abacus Life, Inc. (ABL) Have the Potential to Rally 34.62% as Wall Street Analysts Expect?
The mean of analysts' price targets for Abacus Life, Inc. (ABL) points to a 34.6% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
09/18 16:15 EST - globenewswire.com
Abacus Life Policy Value Calculator Surpasses Milestone of 150,000 Policy Valuations
ORLANDO, Fla., Sept. 18, 2024 (GLOBE NEWSWIRE) -- Abacus Life, Inc. (“Abacus” or the “Company”) (NASDAQ: ABL), a leading global alternative asset manager focused on lifespan-based financial products, today announced that its popular Abacus Policy Value Calculator, which recently launched its newest generation, has surpassed 150,000 individual submissions from insureds, totaling more than $87 billion in face value.
Abacus Life Policy Value Calculator Surpasses Milestone of 150,000 Policy Valuations
ORLANDO, Fla., Sept. 18, 2024 (GLOBE NEWSWIRE) -- Abacus Life, Inc. (“Abacus” or the “Company”) (NASDAQ: ABL), a leading global alternative asset manager focused on lifespan-based financial products, today announced that its popular Abacus Policy Value Calculator, which recently launched its newest generation, has surpassed 150,000 individual submissions from insureds, totaling more than $87 billion in face value.
09/16 16:15 EST - globenewswire.com
Corey McLaren Joins Abacus Life (ABL) as Managing Director, Capital Markets
ORLANDO, Fla., Sept. 16, 2024 (GLOBE NEWSWIRE) -- Abacus Life, Inc. (“Abacus” or the “Company”) (NASDAQ: ABL), a leading global alternative asset manager focused on lifespan-based financial products, today announced that Corey McLaren has joined Abacus as Managing Director, Capital Markets.
Corey McLaren Joins Abacus Life (ABL) as Managing Director, Capital Markets
ORLANDO, Fla., Sept. 16, 2024 (GLOBE NEWSWIRE) -- Abacus Life, Inc. (“Abacus” or the “Company”) (NASDAQ: ABL), a leading global alternative asset manager focused on lifespan-based financial products, today announced that Corey McLaren has joined Abacus as Managing Director, Capital Markets.
09/02 13:20 EST - zacks.com
Can Abacus Life, Inc. (ABL) Run Higher on Rising Earnings Estimates?
Abacus Life, Inc. (ABL) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
Can Abacus Life, Inc. (ABL) Run Higher on Rising Earnings Estimates?
Abacus Life, Inc. (ABL) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
08/26 10:55 EST - zacks.com
Wall Street Analysts Predict a 32.72% Upside in Abacus Life, Inc. (ABL): Here's What You Should Know
The consensus price target hints at a 32.7% upside potential for Abacus Life, Inc. (ABL). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
Wall Street Analysts Predict a 32.72% Upside in Abacus Life, Inc. (ABL): Here's What You Should Know
The consensus price target hints at a 32.7% upside potential for Abacus Life, Inc. (ABL). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
08/19 08:00 EST - globenewswire.com
Abacus Life and Lorisco Life Announce Launch of PREADISAN™ to Improve Health Predictions
ORLANDO, Fla and NEW YORK, Aug. 19, 2024 (GLOBE NEWSWIRE) -- Abacus Life, Inc. (“Abacus”) (NASDAQ: ABL), a pioneering alternative asset manager specializing in longevity and actuarial technology, and Lorisco Life LLC (“Lorisco”), a health prediction company using modern proteomics and machine learning to accurately forecast health events, today announced a new partnership and product launch to revolutionize longevity-based health prediction and actuarial technology.
Abacus Life and Lorisco Life Announce Launch of PREADISAN™ to Improve Health Predictions
ORLANDO, Fla and NEW YORK, Aug. 19, 2024 (GLOBE NEWSWIRE) -- Abacus Life, Inc. (“Abacus”) (NASDAQ: ABL), a pioneering alternative asset manager specializing in longevity and actuarial technology, and Lorisco Life LLC (“Lorisco”), a health prediction company using modern proteomics and machine learning to accurately forecast health events, today announced a new partnership and product launch to revolutionize longevity-based health prediction and actuarial technology.
08/12 10:56 EST - seekingalpha.com
Abacus Life, Inc. (ABL) Q2 2024 Earnings Call Transcript
Abacus Life, Inc. (NASDAQ:ABL ) Q2 2024 Earnings Conference Call August 12, 2024 9:00 AM ET Company Participants Garrett Edson - Managing Director ICR Jay Jackson - Chief Executive Officer Bill McCauley - Chief Financial Officer Conference Call Participants Crispin Love - Piper Sandler Andrew Kligerman - TD Securities Matthew Howlett - B. Riley Securities Operator Greetings and welcome to Abacus Life Second Quarter '24 Earnings Call.
Abacus Life, Inc. (ABL) Q2 2024 Earnings Call Transcript
Abacus Life, Inc. (NASDAQ:ABL ) Q2 2024 Earnings Conference Call August 12, 2024 9:00 AM ET Company Participants Garrett Edson - Managing Director ICR Jay Jackson - Chief Executive Officer Bill McCauley - Chief Financial Officer Conference Call Participants Crispin Love - Piper Sandler Andrew Kligerman - TD Securities Matthew Howlett - B. Riley Securities Operator Greetings and welcome to Abacus Life Second Quarter '24 Earnings Call.
08/12 07:00 EST - globenewswire.com
Abacus Life Reports Second Quarter 2024 Results
- Second Quarter 2024 Total Revenue More Than Doubled Year-over-Year to $29.1 Million - - Net Income of $0.8 Million; Adjusted Net Income Grows 75% Year-over-Year to $11.8 Million - - Adjusted EBITDA Grows 83% Year-over-Year to $16.7 Million - ORLANDO, Fla., Aug. 12, 2024 (GLOBE NEWSWIRE) -- Abacus Life, Inc. (“Abacus” or the “Company”) (NASDAQ: ABL), a pioneering alternative asset manager specializing in longevity and actuarial technology, today reported results for the second quarter ended June 30, 2024.
Abacus Life Reports Second Quarter 2024 Results
- Second Quarter 2024 Total Revenue More Than Doubled Year-over-Year to $29.1 Million - - Net Income of $0.8 Million; Adjusted Net Income Grows 75% Year-over-Year to $11.8 Million - - Adjusted EBITDA Grows 83% Year-over-Year to $16.7 Million - ORLANDO, Fla., Aug. 12, 2024 (GLOBE NEWSWIRE) -- Abacus Life, Inc. (“Abacus” or the “Company”) (NASDAQ: ABL), a pioneering alternative asset manager specializing in longevity and actuarial technology, today reported results for the second quarter ended June 30, 2024.
07/22 11:10 EST - zacks.com
Abacus Life, Inc. (ABL) Stock Jumps 20.3%: Will It Continue to Soar?
Abacus Life, Inc. (ABL) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
Abacus Life, Inc. (ABL) Stock Jumps 20.3%: Will It Continue to Soar?
Abacus Life, Inc. (ABL) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
07/18 16:15 EST - globenewswire.com
Abacus Life Provides Preliminary Second Quarter 2024 Results
- Expects Total Revenue Between $28.0 and $30.0 Million; Grows 146-163% Year-over-Year - - Expects Net Income Between $0.0 and $1.0 Million - - Expects Adjusted EBITDA Between $15.0 and $17.0 Million; Grows 64-86% Year-over-Year - - Schedules Second Quarter 2024 Earnings Release and Conference Call for Monday, August 12, 2024 - ORLANDO, Fla., July 18, 2024 (GLOBE NEWSWIRE) -- Abacus Life, Inc. (“Abacus” or the “Company”) (NASDAQ: ABL), a pioneering alternative asset manager specializing in longevity and actuarial technology, today announced preliminary unaudited financial results for the second quarter ended June 30, 2024.
Abacus Life Provides Preliminary Second Quarter 2024 Results
- Expects Total Revenue Between $28.0 and $30.0 Million; Grows 146-163% Year-over-Year - - Expects Net Income Between $0.0 and $1.0 Million - - Expects Adjusted EBITDA Between $15.0 and $17.0 Million; Grows 64-86% Year-over-Year - - Schedules Second Quarter 2024 Earnings Release and Conference Call for Monday, August 12, 2024 - ORLANDO, Fla., July 18, 2024 (GLOBE NEWSWIRE) -- Abacus Life, Inc. (“Abacus” or the “Company”) (NASDAQ: ABL), a pioneering alternative asset manager specializing in longevity and actuarial technology, today announced preliminary unaudited financial results for the second quarter ended June 30, 2024.
07/18 16:05 EST - globenewswire.com
Abacus Life Announces Agreement to Acquire Carlisle Management Company SCA
Acquisition accelerates Abacus' expansion as a global alternative asset manager and origination company Deal will add up to $2 billion in AUM to Abacus ORLANDO, Fla., July 18, 2024 (GLOBE NEWSWIRE) -- Abacus Life, Inc. (“Abacus” or the “Company”) (NASDAQ: ABL), a leading buyer of life insurance policies and vertically integrated alternative asset manager specializing in specialty insurance products, today announced a definitive agreement to acquire Carlisle Management Company SCA (“Carlisle”), a leading Luxembourg-based investment manager in the life settlement space, for approximately $200 million.
Abacus Life Announces Agreement to Acquire Carlisle Management Company SCA
Acquisition accelerates Abacus' expansion as a global alternative asset manager and origination company Deal will add up to $2 billion in AUM to Abacus ORLANDO, Fla., July 18, 2024 (GLOBE NEWSWIRE) -- Abacus Life, Inc. (“Abacus” or the “Company”) (NASDAQ: ABL), a leading buyer of life insurance policies and vertically integrated alternative asset manager specializing in specialty insurance products, today announced a definitive agreement to acquire Carlisle Management Company SCA (“Carlisle”), a leading Luxembourg-based investment manager in the life settlement space, for approximately $200 million.
06/24 16:21 EST - globenewswire.com
Abacus Life Announces Closing of Public Offering of 11,500,000 Shares of Common Stock
ORLANDO, Fla., June 24, 2024 (GLOBE NEWSWIRE) -- Abacus Life, Inc. (“Abacus” or the “Company”) (NASDAQ: ABL), a pioneering alternative asset manager specializing in longevity and actuarial technology, today announced the closing of its oversubscribed underwritten public offering of 11,500,000 shares of its common stock, including the exercise in full by the underwriters of their option to purchase an additional 1,500,000 shares of common stock, at the public offering price of $8.00 per share. The gross proceeds raised in the offering, before underwriting discounts and commissions and estimated expenses of the offering, were approximately $92 million.
Abacus Life Announces Closing of Public Offering of 11,500,000 Shares of Common Stock
ORLANDO, Fla., June 24, 2024 (GLOBE NEWSWIRE) -- Abacus Life, Inc. (“Abacus” or the “Company”) (NASDAQ: ABL), a pioneering alternative asset manager specializing in longevity and actuarial technology, today announced the closing of its oversubscribed underwritten public offering of 11,500,000 shares of its common stock, including the exercise in full by the underwriters of their option to purchase an additional 1,500,000 shares of common stock, at the public offering price of $8.00 per share. The gross proceeds raised in the offering, before underwriting discounts and commissions and estimated expenses of the offering, were approximately $92 million.
06/21 08:42 EST - investorplace.com
Why Is Abacus Life (ABL) Stock Down 18% Today?
Abacus Life (NASDAQ: ABL ) stock is falling on Friday after the alternative asset manager and market maker announced the pricing of a public offering for its shares. Abacus Life is selling 10 million shares of ABL stock for $8 each.
Why Is Abacus Life (ABL) Stock Down 18% Today?
Abacus Life (NASDAQ: ABL ) stock is falling on Friday after the alternative asset manager and market maker announced the pricing of a public offering for its shares. Abacus Life is selling 10 million shares of ABL stock for $8 each.
06/21 05:42 EST - benzinga.com
Smith & Wesson Brands, Abacus Life And Other Big Stocks Moving Lower In Friday's Pre-Market Session
U.S. stock futures were slightly lower this morning, with the Dow futures falling around 0.1% on Friday.
Smith & Wesson Brands, Abacus Life And Other Big Stocks Moving Lower In Friday's Pre-Market Session
U.S. stock futures were slightly lower this morning, with the Dow futures falling around 0.1% on Friday.